Medicine Man Technologies, Inc. (SHWZ)
| Previous Close | 0.6453 |
| Open | 0.6550 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.6500 - 0.6700 |
| 52 Week Range | 0.4800 - 1.5500 |
| Volume | |
| Avg. Volume | 67,480 |
| Market Cap | 50.677M |
| Beta (5Y Monthly) | 1.48 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results
Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), today announced financial and operational results for the fourth quarter and full year ended December 31, 2023.
- CNW Group
Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET
Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, March 27, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the fourth quarter and full year ended December 31, 2023. The Company's results will be reported in a press release prior to the call.
- CNW Group
Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer
Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced that Forrest Hoffmaster, the Company's Chief Financial Officer, has been appointed to the additional role of interim Chief Executive Officer ("CEO"). This follows Nirup Krishnamurthy's resignation as CEO and as a member of the Board of Directors ("Board"), effective February 20, 2024, due to personal reasons.
